Hypocalcemia / Milk Fever (cattle, sheep, goats)

Hypocalcemia, commonly known as milk fever in cattle or lambing sickness in sheep, is a severe metabolic disorder characterized by dangerously low levels of calcium in the blood that occurs primarily around the time of parturition and early lactation. Despite its common name, milk fever does not involve an elevated body temperature; rather, it refers to the acute depletion of blood calcium that occurs when the sudden demands of milk production exceed the animal's ability to mobilize calcium from bones and absorb it from the diet. This condition represents one of the most significant metabolic emergencies in dairy production and can be rapidly fatal if not treated promptly with intravenous calcium supplementation.

Milk fever predominantly affects dairy cattle, particularly high-producing cows in their third or subsequent lactations, though it also occurs in sheep, goats, and occasionally other ruminant species. In dairy cattle, the condition typically develops within the first 72 hours after calving, with the highest incidence occurring within 24 hours of delivery. Sheep and goats are most commonly affected in late pregnancy, particularly when carrying multiple fetuses, though postpartum cases also occur. The condition is relatively common in intensive dairy production systems, with incidence rates in dairy cattle herds ranging from 5% to over 10% in some populations, while subclinical hypocalcemia (low blood calcium without obvious clinical signs) may affect 50% or more of older dairy cows at calving.

The economic and welfare impact of hypocalcemia in dairy production is substantial. Direct losses include animal deaths, which can occur within hours if treatment is not provided, as well as costs of veterinary treatment and the labor required for intensive monitoring and care of affected animals. Indirect economic impacts may be even greater, as hypocalcemia is associated with increased risk of numerous other periparturient disorders including ketosis, displaced abomasum, retained placenta, metritis, and mastitis. Subclinical hypocalcemia, even without obvious clinical signs, reduces rumen function, depresses feed intake, impairs immune function, and decreases milk production, creating cascading effects on overall herd productivity and animal welfare.

With prompt recognition and appropriate treatment, clinical milk fever has an excellent prognosis, with most affected animals responding dramatically to intravenous calcium therapy and returning to normal function within hours. However, prevention is far preferable to treatment, and modern dairy management places significant emphasis on nutritional strategies during the dry period and transition phase to support calcium metabolism and prevent hypocalcemia. Understanding the underlying physiology of calcium regulation and implementing evidence-based prevention protocols can dramatically reduce the incidence of this condition and its associated complications, making milk fever prevention a cornerstone of successful transition cow management programs.

The primary cause of hypocalcemia is the sudden, dramatic increase in calcium demand that occurs at the onset of lactation, combined with a delay in the body's ability to adapt to this increased need. A high-producing dairy cow may secrete 20 to 30 grams of calcium in colostrum on the first day after calving, which represents many times the amount normally circulating in her bloodstream. The body must rapidly mobilize calcium from bone stores and increase intestinal calcium absorption to meet this demand, but these homeostatic mechanisms require time to fully activate. When the response is too slow or inadequate, blood calcium levels fall precipitously, leading to the clinical signs of milk fever. This fundamental mismatch between sudden demand and delayed adaptation is the core mechanism underlying parturient hypocalcemia.

Genetic and breed predisposition to milk fever is well documented, with certain breeds and family lines showing significantly higher susceptibility. Jersey cattle appear to have higher incidence rates than Holsteins when compared at similar production levels, possibly due to differences in calcium metabolism and colostrum calcium content. Within breeds, there is heritable variation in milk fever susceptibility, and daughters of cows that have experienced milk fever are at increased risk themselves. This genetic component suggests that calcium regulatory mechanisms vary among individuals, with some animals less efficient at rapidly mobilizing bone calcium or upregulating intestinal calcium absorption in response to the demands of lactation.

Environmental and management factors strongly influence the risk of hypocalcemia, particularly nutritional management during the dry period. Diets high in potassium during the dry period create a metabolic alkalosis that impairs the body's ability to mobilize calcium from bone and respond to parathyroid hormone. This is one of the most significant controllable risk factors for milk fever. Conversely, feeding anionic salts or formulating low-potassium diets to maintain a negative dietary cation-anion difference (DCAD) during the prepartum period helps acidify the blood slightly, improving calcium metabolism and significantly reducing milk fever risk. Excessive calcium supplementation during the dry period paradoxically increases milk fever risk by down-regulating calcium mobilization mechanisms.

Risk factors for hypocalcemia include increasing age and parity, with cows in their third lactation and beyond at much higher risk than first-calf heifers. This age-related increase in risk is attributed to decreased efficiency of calcium absorption and bone mobilization in older animals, as well as higher milk production and thus greater calcium demand. Body condition at calving influences risk, with both over-conditioned and thin cows being at greater risk than those in moderate condition. The level of milk production is also a factor, with higher-producing cows and those with high colostrum calcium concentrations facing greater calcium drain. In sheep, ewes carrying twins or triplets are at particularly high risk due to the fetal calcium demands of multiple pregnancies.

The pathophysiology of hypocalcemia involves the failure of normal calcium homeostatic mechanisms to maintain blood calcium within the narrow range required for normal cellular function. Calcium plays essential roles in muscle contraction, nerve signal transmission, blood clotting, and cellular signaling throughout the body. When blood calcium falls below critical levels, neuromuscular function becomes progressively impaired, initially causing muscle weakness and incoordination, then progressing to recumbency and, if untreated, cardiovascular collapse and death. The heart is particularly sensitive to calcium levels, and cardiac function becomes compromised in severe hypocalcemia. Smooth muscle function is also affected, leading to decreased rumen motility, uterine atony, and teat sphincter relaxation that increases mastitis risk.

Early warning signs of hypocalcemia may be subtle and easily missed, particularly in busy calving operations or pastoral systems where animals receive less intensive observation. Initial symptoms include decreased feed intake in the hours surrounding calving, subtle changes in behavior such as restlessness or mild depression, and fine muscle tremors that may be visible over the shoulder or flank regions. Affected animals may show slightly unsteady gait or reluctance to move, and some develop a characteristic staring expression or dull demeanor. Rumen motility decreases early in the disease process, and manure output may be reduced. These early signs often progress rapidly to more obvious clinical manifestations, sometimes within just one to two hours.

Common symptoms in cattle with clinical milk fever include progressive muscle weakness leading to an inability to stand. In the early ambulatory stage (Stage 1), affected cows can still stand but are unsteady, often shifting weight between their hind legs. They may appear hypersensitive to touch and sound, with fine muscle tremors visible. As the condition progresses to Stage 2, the cow becomes unable to stand but can maintain sternal recumbency (lying on her chest). At this stage, the classic signs include a characteristic S-curve to the neck as the cow turns her head toward her flank, cold extremities including the ears and limbs due to peripheral vasoconstriction, dry muzzle, and dilated pupils that respond sluggishly to light. Heart rate is often elevated, and heart sounds may be weak or irregular. Stage 3 represents severe, life-threatening hypocalcemia where the cow becomes laterally recumbent (flat on her side) and may become comatose. Without immediate treatment, death from cardiovascular collapse typically occurs within hours.

Behavioral changes associated with hypocalcemia include initial restlessness and anxiety, progressing to depression and decreased responsiveness as the condition advances. Affected animals often stop eating and drinking, and rumination ceases. Some cows vocalize abnormally or show signs of discomfort. In the early stages, animals may repeatedly attempt to stand and fail, becoming increasingly distressed with each unsuccessful attempt. As the condition worsens, the animal becomes progressively obtunded, eventually becoming unresponsive to external stimuli in severe cases. These behavioral changes reflect the profound effects of low calcium on nervous system function.

Physical signs of hypocalcemia extend beyond muscle weakness to affect multiple body systems. The gastrointestinal tract shows markedly decreased motility, with reduced or absent rumen contractions detectable on auscultation and physical examination. Bloat may develop due to failure of normal eructation. Uterine motility is reduced, increasing the risk of retained placenta in recently calved animals. The teat sphincter relaxes, leaving the teat canal open and dramatically increasing susceptibility to environmental mastitis pathogens. Body temperature is typically normal or subnormal in uncomplicated milk fever cases, and the presence of fever should prompt investigation for concurrent infections or other conditions. Extremities feel cold to the touch due to poor peripheral circulation.

Symptom progression in untreated hypocalcemia follows a predictable and rapid course. From the first subtle signs, animals may progress through all three stages within just a few hours. Stage 1 may last only 30 minutes to an hour before the animal becomes recumbent. Stage 2 recumbency can progress to Stage 3 lateral recumbency within one to several hours depending on the severity of hypocalcemia and individual animal factors. Once laterally recumbent and comatose, death typically occurs within 12 to 24 hours without treatment, though some animals may die more rapidly from cardiac arrest or aspiration of regurgitated rumen contents. The speed of progression underscores the importance of early recognition and prompt treatment.

Emergency symptoms requiring immediate veterinary intervention include any stage of clinical milk fever, as all affected animals require treatment. However, Stage 3 recumbency with coma represents the most critical emergency and demands immediate intravenous calcium therapy. Signs suggesting cardiac compromise include very weak or irregular pulse, prolonged capillary refill time, and cold, pale mucous membranes. Bloat developing secondary to ruminal atony may require emergency decompression. Any recumbent cow that fails to respond to initial treatment, or that develops complications such as aspiration pneumonia from regurgitation or injuries from struggling to rise, requires intensive veterinary management. Hypocalcemia that occurs before calving (prepartum milk fever) is particularly dangerous and may be complicated by concurrent issues with parturition.

Clinical examination for suspected hypocalcemia focuses on recognizing the characteristic presentation and ruling out other causes of recumbency or weakness in periparturient animals. The veterinarian assesses the animal's mental status, ability to stand or attempts to rise, muscle tone, and reflexes. Heart rate, rhythm, and intensity of heart sounds are evaluated, along with auscultation of the rumen for decreased motility. Rectal temperature is checked to help differentiate from infectious causes of recumbency. The characteristic posture, cold extremities, and timing relative to parturition in a high-risk animal often allow for a presumptive diagnosis to be made rapidly, permitting life-saving treatment to begin before laboratory confirmation is available.

Diagnostic tests for hypocalcemia definitively require measurement of blood calcium levels. Total serum or plasma calcium concentration below approximately 5-6 mg/dL (1.25-1.5 mmol/L) in cattle is consistent with clinical milk fever, though reference ranges vary somewhat between laboratories. Ionized calcium measurement, when available, provides a more accurate assessment of biologically active calcium but is more difficult to obtain accurately. Point-of-care analyzers are increasingly available for immediate calcium measurement on the farm, allowing rapid confirmation of diagnosis. Blood samples may also reveal concurrent metabolic abnormalities such as low phosphorus (hypophosphatemia) or low magnesium (hypomagnesemia), which may complicate the clinical picture and require additional treatment.

Differential diagnosis for recumbent periparturient cattle includes numerous conditions that must be considered, particularly in animals that fail to respond to calcium treatment or have atypical presentations. Toxic mastitis can cause recumbency with concurrent fever and changes in the udder. Metritis or septicemia may cause weakness and depression with fever. Musculoskeletal injuries including hip luxation, tibial or femoral fractures, and obturator nerve paralysis from difficult calving can cause inability to rise with normal mentation. Spinal cord compression or trauma should be considered. Hypomagnesemia (grass tetany) may present similarly but often with more pronounced neurological signs including hyperexcitability and convulsions. Hypophosphatemia, ketosis, and other metabolic disorders may occur concurrently or independently.

Herd-level diagnostics for hypocalcemia involve monitoring and testing that goes beyond individual sick animals to assess subclinical disease in the herd. Subclinical hypocalcemia, where blood calcium is low but animals do not show obvious clinical signs, may affect the majority of cows at calving and causes significant economic losses through its effects on subsequent health and production. Monitoring blood calcium levels in a sample of fresh cows helps determine the extent of subclinical hypocalcemia in the herd. Urine pH testing in close-up dry cows on anionic diets provides feedback on whether the prevention program is effectively acidifying the cows. Analysis of dry cow and close-up diet samples for potassium and other minerals helps optimize nutritional prevention strategies. Tracking the incidence of clinical milk fever and associated periparturient disorders allows assessment of prevention program efficacy over time.

Emergency and immediate treatment for clinical milk fever centers on the administration of calcium solutions intravenously. The standard treatment is slow intravenous infusion of calcium borogluconate solution, typically providing 8 to 12 grams of elemental calcium for a full-sized cow. The infusion must be given slowly, typically over 10 to 20 minutes, while monitoring heart rate and rhythm, as too-rapid administration can cause fatal cardiac arrhythmias. As the calcium infusion proceeds, heart sounds typically become stronger and the rate may initially increase slightly before normalizing. Most animals begin to show improvement during or shortly after the infusion, with increased muscle tone, attempts to rise, and improved mentation. The dramatic response to treatment is one of the most striking therapeutic successes in veterinary medicine.

Medical management protocols for milk fever often include additional calcium administration to sustain blood calcium levels and prevent relapse. Subcutaneous calcium solutions provide slower, more sustained absorption and are commonly given following the initial intravenous treatment. Oral calcium supplements, including calcium propionate, calcium chloride, and various commercial products, may be given to provide additional calcium absorption from the gastrointestinal tract. Phosphorus supplementation is often included as concurrent hypophosphatemia is common. Magnesium supplementation should be provided if hypomagnesemia is documented or suspected. Anti-inflammatory drugs may be administered if the animal has been recumbent for extended periods. It is essential to note that in food-producing animals, all treatments must be documented and appropriate withdrawal times observed for milk and meat.

Surgical options are not directly applicable to the treatment of hypocalcemia itself, but surgical intervention may be required for complications arising from the disease or concurrent conditions. Rumenotomy may occasionally be needed for severe bloat that does not respond to passage of a stomach tube. Emergency cesarean section may be necessary if hypocalcemia occurs before completion of calving. Animals that develop traumatic injuries during recumbency, such as hip luxation, may require orthopedic assessment. Mastitis developing due to teat sphincter relaxation may in rare cases require surgical intervention if severe.

Supportive care for animals with milk fever includes nursing care for recumbent patients, which is critical for preventing secondary complications. Recumbent animals should be positioned in sternal recumbency on a well-bedded, non-slippery surface to prevent muscle and nerve damage and aspiration of rumen contents. The animal should be rolled from side to side every few hours if recumbent for extended periods. Adequate water and feed should be offered once the animal is alert enough to swallow safely. Hip lifters or slings may be used cautiously to assist animals attempting to stand, though care must be taken not to cause injury. Protection from environmental temperature extremes is important. Milking should be delayed or limited in fresh cows to reduce further calcium drain until the animal has stabilized.

Herd treatment protocols following a case of clinical milk fever involve reviewing and intensifying prevention strategies for other at-risk animals. Other close-up or fresh cows should be considered at higher risk, particularly if management factors contributing to the case are identified. Prophylactic oral calcium supplementation at calving may be implemented for high-risk cows. Review of the dry cow and close-up nutrition program should be undertaken with particular attention to potassium levels and DCAD. Monitoring of fresh cows should be intensified, with particular attention to early signs of hypocalcemia. Any cows with borderline signs should receive prompt attention and possibly prophylactic calcium supplementation.

Treatment decisions in cases of milk fever are generally straightforward given the excellent prognosis with appropriate treatment. However, economic considerations arise in cases with complications or recurrent disease. Animals that fail to respond to treatment or develop complications such as prolonged recumbency with muscle and nerve damage (downer cow syndrome) face uncertain prognoses and may require difficult decisions about continuing treatment versus euthanasia. Repeated episodes of milk fever in the same animal, particularly if they occur despite prevention efforts, may warrant consideration of culling after the current lactation. The costs of prevention programs should be weighed against the costs of treating clinical disease and its complications, with prevention almost invariably proving more economical.

Recovery timeline for uncomplicated milk fever following appropriate treatment is remarkably rapid and dramatic. Many animals begin showing improvement during the calcium infusion itself, with increased muscle strength and alertness. The majority of animals treated in Stage 2 recumbency will stand within 30 minutes to 2 hours following intravenous calcium administration. Animals treated in earlier stages typically respond even more quickly. Once standing, recovery of normal function including appetite, rumination, and mobility usually occurs within 12 to 24 hours. Full restoration of milk production and normal metabolic function typically occurs over the following few days. This rapid and complete recovery in responsive cases makes milk fever one of the most rewarding conditions to treat in farm animal practice.

Post-treatment care and monitoring are essential to ensure continued recovery and identify animals at risk for relapse or complications. Blood calcium levels may fall again following the initial response to treatment, and approximately 25-30% of treated animals experience relapse within 24-48 hours, requiring additional treatment. Close observation for the first 24-48 hours following treatment is important, with attention to appetite, attitude, ability to stand, and any return of clinical signs. Rumen function should be monitored, as prolonged ruminal atony may require additional intervention. Fresh water and palatable feed should be offered to encourage intake. Milking may be limited initially to reduce calcium drain, with gradual return to normal milking frequency as the animal stabilizes.

Prognosis for animals with milk fever depends on the stage at which treatment is initiated and whether complications develop. Animals treated promptly in Stage 1 or early Stage 2 have excellent prognoses approaching 95% or higher for complete recovery. Prognosis decreases for animals in Stage 3 or those recumbent for extended periods before treatment. Development of downer cow syndrome, where an animal remains unable to rise despite correction of calcium levels, carries a guarded prognosis, with many affected animals failing to recover. Concurrent conditions such as mastitis, metritis, or other periparturient diseases may complicate recovery. Recurrent milk fever in subsequent lactations occurs in some animals, particularly those with inherent susceptibility.

Return to production considerations following recovery from milk fever include gradual return to normal milking frequency and monitoring for associated conditions that may affect production. Animals that have experienced clinical milk fever are at increased risk for other periparturient disorders including ketosis, displaced abomasum, mastitis, and retained placenta, and should be monitored accordingly. Milk production may be somewhat depressed in the days following the episode but typically returns to expected levels within one to two weeks in uncomplicated cases. Reproductive performance may be affected, with some studies suggesting delayed return to estrus and lower conception rates in cows that have experienced clinical milk fever. Nutritional support and attention to energy balance help optimize recovery and subsequent production.

Vaccination protocols are not applicable to milk fever prevention as this is a metabolic rather than infectious condition. However, maintaining overall herd health through appropriate vaccination programs reduces the stress of concurrent infections that could exacerbate metabolic challenges around calving. Animals in good health with well-functioning immune systems are better equipped to handle the metabolic demands of transition and early lactation.

Biosecurity measures are not directly relevant to milk fever prevention, though good general biosecurity supporting overall herd health indirectly benefits metabolic health during the transition period. Stress reduction through appropriate handling and minimizing environmental challenges around calving supports normal physiological adaptation to lactation.

Nutritional prevention strategies are the cornerstone of milk fever control and focus primarily on preparing the cow's calcium regulatory systems for the demands of lactation. The most evidence-based approach involves manipulation of the dietary cation-anion difference (DCAD) during the close-up dry period, typically the final three weeks before calving. By feeding anionic salts or formulating diets with low potassium content to achieve a negative DCAD, the cow's blood is mildly acidified, which enhances the responsiveness of bone and intestine to parathyroid hormone. This primes the calcium mobilization systems so they can respond rapidly when calcium demands surge at calving. Target urine pH in close-up cows on acidified diets is typically 6.0-6.5 in Holsteins.

Management practices for milk fever prevention include identification and special attention to high-risk animals including older cows, those with previous milk fever history, and known high producers. Some operations provide prophylactic oral calcium supplementation to high-risk cows at calving, using products such as calcium propionate, calcium chloride gel, or calcium boluses. Vitamin D supplementation during the dry period may be helpful, as vitamin D is essential for calcium absorption. Avoiding over-conditioning of dry cows helps reduce milk fever risk. Minimizing stress around calving and ensuring adequate access to water and feed immediately after calving support normal calcium metabolism. Some operations implement testing of close-up cows' blood calcium or urine pH to monitor the effectiveness of prevention programs.

Quarantine and testing protocols are not specifically relevant to milk fever prevention, though new animals entering the herd should be assessed for body condition and nutritional status. Animals purchased close to calving represent higher risk if their pre-purchase nutritional management is unknown. Obtaining diet information from the source farm and transitioning carefully to the new operation's close-up program helps reduce risk. Routine monitoring of fresh cow health metrics including blood calcium in a sample of animals provides ongoing assessment of prevention program effectiveness.

Daily management and monitoring for milk fever prevention begins with the dry cow program and intensifies as calving approaches. Close-up dry cows should be monitored daily for signs of imminent calving and any early indicators of metabolic problems. Feed intake should be observed, as decreased intake near calving is a risk factor for milk fever and other metabolic disorders. Fresh cows require particularly close observation during the first 72 hours after calving, with attention to appetite, attitude, rumen function, and ability to stand and move normally. Any subtle signs suggesting early hypocalcemia warrant intervention including oral calcium supplementation or, if signs progress, veterinary attention for intravenous treatment.

Housing and environmental management during the transition period should minimize stress and support normal feeding behavior. Close-up dry cows benefit from housing that provides adequate space, comfortable resting areas, and easy access to feed and water. Overcrowding increases stress and reduces feed intake. The calving environment should be clean, well-bedded, and allow for easy observation while providing a quiet, low-stress setting. Fresh cows should be housed with excellent footing to reduce injury risk, especially important given the muscle weakness that may occur with even subclinical hypocalcemia. Protection from heat stress is particularly important as heat stress impairs feed intake and exacerbates metabolic disorders.

Herd health programs addressing milk fever prevention should include regular review and optimization of dry cow and transition cow nutrition in consultation with a nutritionist and veterinarian. Monitoring programs may include routine blood testing of fresh cows for calcium and other metabolic indicators, urine pH testing of close-up cows on acidified diets, and tracking of clinical milk fever incidence and related disorders. Analysis of herd data helps identify risk factors and assess the effectiveness of prevention strategies. Target goals typically include clinical milk fever incidence below 5% and subclinical hypocalcemia affecting fewer than 15% of cows at calving.

Record keeping and monitoring for milk fever should document all cases of clinical disease including date, animal identification, treatment administered, response to treatment, and any complications. This information allows tracking of trends over time and identification of high-risk families or management periods. Fresh cow health monitoring programs may include recording of blood calcium results, treatment for any metabolic disorder, and production and reproductive outcomes. Linking milk fever incidence to nutritional program changes, seasonal factors, or management changes helps optimize prevention efforts. Records of dry cow diet formulation and urine pH monitoring results provide documentation of prevention program implementation.

Economic considerations for milk fever management include both the costs of prevention programs and the costs of clinical disease and its complications. While anionic salt supplementation and other prevention measures add to feed costs during the dry period, these costs are generally far outweighed by the savings from reduced clinical milk fever and, importantly, the reduced incidence of associated transition disorders including ketosis, displaced abomasum, retained placenta, metritis, and mastitis. Subclinical hypocalcemia alone has been estimated to cost dairy operations hundreds of dollars per affected cow in lost production and increased disease risk. Investment in effective transition cow programs including appropriate facilities, nutrition, and monitoring represents one of the best returns on investment in dairy management.

High-risk breeds and species for hypocalcemia include certain dairy breeds that have been selected for high milk production and thus face greater calcium demands at the onset of lactation. Jersey cattle appear to have higher susceptibility to milk fever than Holstein-Friesian cattle when compared at similar production levels, possibly due to higher calcium content in Jersey colostrum and milk. Guernsey and Ayrshire cattle also appear to have elevated risk compared to some other breeds. Among sheep, the prolific breeds that commonly produce twins or triplets, such as Finn sheep and Romanov crosses, face higher risk due to the calcium demands of multiple fetuses and the subsequent higher milk production. High-producing dairy goat breeds including Saanen, Alpine, and LaMancha are at risk, particularly as they age and reach higher production levels.

Production type considerations significantly influence milk fever risk, with the condition being primarily a disease of dairy animals rather than beef cattle or meat-producing sheep and goats. Within dairy cattle, risk increases dramatically with production level, as higher-producing cows face greater calcium demands. The highest-risk animals are high-producing dairy cows in their third or later lactation with a history of high milk production in previous lactations. Beef cattle, with their generally lower milk production, experience milk fever infrequently, though cases do occur particularly in older cows or those with high genetic potential for milk production. Similarly, meat-producing sheep breeds face lower risk than dairy sheep, though ewes carrying multiples remain at risk regardless of production type.

Genetic selection and testing for milk fever susceptibility is an area of ongoing research and increasing application in dairy cattle breeding. The heritable component of milk fever susceptibility has been recognized, and some breeding programs now include resistance to milk fever as a component of health indexes. Genomic testing can identify animals carrying genetic variants associated with higher or lower milk fever risk. Producers can use this information in mating decisions and when selecting replacements. Within herds, daughters of cows with milk fever history should be considered higher risk and targeted for intensified prevention measures. Selection for improved calcium metabolism and lower disease susceptibility must be balanced with other breeding goals including production, fertility, and longevity.

Commonly co-occurring conditions with hypocalcemia include other metabolic and periparturient disorders that share risk factors or arise as complications. Ketosis frequently occurs alongside or following milk fever, as decreased feed intake associated with hypocalcemia predisposes to negative energy balance. Displaced abomasum incidence is elevated in cows that have experienced milk fever, likely due to decreased gastrointestinal motility. Retained placenta occurs more commonly when uterine motility is impaired by low calcium levels. Metritis risk is increased due to both the retained placenta and the immune suppression associated with calcium deficiency. Mastitis incidence is elevated due to the relaxation of the teat sphincter that allows environmental pathogen entry. This clustering of periparturient disorders is often referred to as the "transition cow disease complex" and underscores the importance of preventing hypocalcemia as a means of reducing risk for multiple conditions.

Conditions with similar symptoms to milk fever that must be considered in differential diagnosis include other causes of weakness and recumbency in periparturient cattle. Hypomagnesemia (grass tetany) causes neuromuscular signs but typically with more pronounced hyperexcitability, muscle fasciculations, and convulsions rather than the progressive weakness of milk fever. Hypophosphatemia can cause recumbency and may occur concurrently with hypocalcemia or independently. Toxic mastitis causes recumbency with depression and fever, along with obvious udder changes. Calving injuries including hip luxation, pelvic fractures, and nerve damage cause inability to rise with normal mentation. In sheep, pregnancy toxemia (twin lamb disease) causes recumbency and depression in late pregnancy but is characterized by hypoglycemia rather than hypocalcemia.

Complications and sequelae of milk fever include downer cow syndrome, which occurs when an animal remains unable to rise despite correction of blood calcium levels and represents one of the most challenging complications. Prolonged recumbency leads to muscle and nerve damage that prevents recovery even when the underlying metabolic cause has been resolved. Aspiration pneumonia may develop if recumbent animals regurgitate rumen contents. Muscle necrosis from pressure damage can cause myoglobinuria and kidney damage. Secondary infections including mastitis and metritis commonly develop. Animals that recover from clinical milk fever have increased risk for recurrence in subsequent lactations and may experience reduced longevity. The cascading effects on other health conditions make milk fever prevention far preferable to treatment of clinical disease.